This information was published on 2025-05-16T14:35:32 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2546023 (IR 1853002) |
| (220) |
01 Apr 2025
|
| (300) |
US, 07 Oct 2024, 98788289
|
| (511) (510) |
Class 1
Active chemical ingredients for use in the manufacture of anti-cancer drugs. Class 5 Biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer. |
| (540) | MABETULENE |
| (550) | Word |
| (730) |
Gerosynth Laboratories Inc.
|
Find out more about publications on the About page.